NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / Technology News / COVID-19 survivors at risk of developing serious blood clots: Study
    COVID-19 survivors at risk of developing serious blood clots: Study
    Technology

    COVID-19 survivors at risk of developing serious blood clots: Study

    Written by Manzoor-ul-Hassan
    Edited by Ramya Patelkhana
    April 07, 2022 | 09:39 pm 3 min read
    COVID-19 survivors at risk of developing serious blood clots: Study
    Researchers found an increased risk of deep vein thrombosis, pulmonary embolism, and bleeding in patients for up to 6 months after COVID-19.

    A new study has found people infected with SARS-CoV-2—the virus that causes COVID-19—are at a higher risk of developing serious blood clots for up to six months, even in the case of mild infections. The study published in The BMJ journal also says patients with underlying illnesses and severe COVID-19 infections and those infected during the first pandemic wave are at a greater risk.

    Why does this story matter?

    Researchers at Sweden's Umea University, who conducted the study, said their findings not only back measures for preventing thrombotic events but also highlight the importance of COVID-19 vaccination. Using Sweden's national registries, the scientists identified over one million people with confirmed COVID-19 infections between February 2020 and May 2021 and compared them to over four million people who didn't have a positive SARS-CoV-2 result.

    Different types of clots in COVID-19 survivors

    The researchers discovered higher risks of deep vein thrombosis (blood clots in legs) for up to three months following COVID-19, pulmonary embolism (clots in lungs) up to six months, and internal bleeding for up to two months. For the study, they first calculated incidences of such events in a control period—before and after COVID-19—and compared them to the rates during different intervals after COVID-19.

    Comparison of thrombotic events in COVID-19 individuals, control group

    Later, the scientists also calculated rates of the aforementioned thrombotic events between 1-30 days after the COVID-19 diagnosis in the group with COVID-19 individuals. These results were then compared to the rates in the control group, too. Their findings showed that the risks for deep vein thrombosis, pulmonary embolism, and bleeding events jumped remarkably 90 days, 180 days, and 60 days, respectively, after COVID-19.

    Pulmonary embolism risk 33 times higher in first 30 days

    The study also found that in the first 30 days after infection, the risk of deep vein thrombosis increased five-fold, while a 33-fold rise in the risk of pulmonary embolism and a nearly twofold increase in the risk of internal bleeding events were observed.

    Occurrence of thrombotic events in both groups

    Moreover, the researchers found that a first deep vein thrombosis occurred in 401 COVID-19 group participants, while the same was reported in 267 individuals in the control group. Also, there were 1,761 cases of first pulmonary embolism events in the COVID-19 group compared to 171 among the control patients, while first bleeding events were observed in 1,002 patients with COVID-19 and 1,292 control patients.

    Risk higher in severe, first COVID-19 wave cases

    The researchers discovered that the clot risk was the highest for individuals who have had more severe COVID-19 infections, particularly during the first wave compared to the second and third waves, when the treatments improved and vaccinations for certain age groups had started.

    Mild cases too face the threat of serious clot

    An elevated risk of deep vein thrombosis and pulmonary embolism was also found among mild, non-hospitalized COVID-19 cases. However, there was no increased risk of internal bleeding in such cases. As this was an observational study, the researchers could not establish the cause behind the higher clot risk after COVID-19 infection and they also acknowledged numerous limitations that might have impacted the findings.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Coronavirus
    SARS-CoV-2
    COVID-19

    Coronavirus

    COVID-19: India reports 1,660 new cases, 4,100 more deaths Union Health Ministry
    COVID-19: India reports 1,938 new cases; 67 more fatalities India
    COVID-19: Cases surge in Asia, Europe; WHO issues warning World Health Organization
    South Korea logs record-high 6 lakh daily COVID-19 cases South Korea

    SARS-CoV-2

    Coronavirus may remain active for longer than recommended quarantine: Study United States of America
    Mu, C.1.2 variants of SARS-CoV2 not found in India: INSACOG INSACOG
    COVID-19 'not developed' as a biological weapon: US Intelligence Community United States of America
    COVID-19 most-transmissible two days before, three days after symptoms appear Research

    COVID-19

    COVID-19: India logs 1,033 new cases, 43 more deaths COVID-19 India
    COVID-19 XE variant: India's first case detected in Mumbai India
    COVID-19: India logs 1,086 new cases, 71 more deaths India
    COVID-19: At 16,412, China reports highest single-day cases so far Shanghai
    Next News Article

    Love Technology News?

    Subscribe to stay updated.

    Science Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023